01675nas a2200277   4500000000100000008004100001653003000042653001500072653001300087653002100100653003300121653001200154653001100166653001800177653002100195653002600216100001200242700001300254700001300267245006900280856007000349300001100419490000700430520094600437022001401383       2012                            d10aWorld Health Organization10aTrichiasis10aTrachoma10aRural Population10aPractice Guidelines as Topic10aPoverty10aHumans10aGlobal health10aEndemic Diseases10aChlamydia trachomatis1 aRajak S1 aCollin R1 aBurton M00aTrachomatous trichiasis and its management in endemic countries.  uhttp://www.surveyophthalmol.com/article/S0039-6257(11)00175-5/pdf  a105-350 v573 a<p>Trichiasis is the sight-threatening consequence of conjunctival scarring in trachoma, the most common infectious cause of blindness worldwide. Trachomatous trichiasis is the result of multiple infections from childhood with Chlamydia trachomatis, which causes recurrent chronic inflammation in the tarsal conjunctiva. This produces conjunctival scarring, entropion, trichiasis, and ultimately blinding corneal opacification. The disease causes painful, usually irreversible sight loss. Over eight million people have trachomatous trichiasis, mostly those living in poor rural communities in 57 endemic countries. The global cost is estimated at US$ 5.3 billion. The WHO recommends surgery as part of the SAFE strategy for controlling the disease.We examine the principles of clinical management, treatment options, and the challenging issues of providing the quantity and quality of surgery that is needed in resource-poor settings.</p>
  a1879-3304